Sundaram Multi Pap Ltd is Rated Strong Sell

1 hour ago
share
Share Via
Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMojo, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Sundaram Multi Pap Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Sundaram Multi Pap Ltd indicates a cautious stance for investors, suggesting that the stock currently exhibits significant risks and challenges that outweigh potential rewards. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s investment appeal and risk profile.

Quality Assessment

As of 04 March 2026, Sundaram Multi Pap Ltd’s quality grade remains below average. The company demonstrates weak long-term fundamental strength, with an average Return on Capital Employed (ROCE) of just 1.94%. This low ROCE suggests that the company is not efficiently generating profits from its capital base, which is a critical concern for investors seeking sustainable growth. Additionally, operating profit growth over the last five years has been modest, at an annual rate of 13.96%, indicating limited expansion in core business profitability.

Another quality concern is the company’s ability to service its debt. The average EBIT to Interest ratio stands at a poor 0.40, signalling that earnings before interest and tax are insufficient to comfortably cover interest expenses. This weak debt servicing capacity increases financial risk, especially in volatile market conditions.

Valuation Considerations

The valuation grade for Sundaram Multi Pap Ltd is classified as risky. Despite the company’s profits rising by 146.9% over the past year, the stock’s price performance has been disappointing, with a return of -35.78% during the same period. This divergence suggests that the market perceives underlying risks or uncertainties that are not fully captured by profit growth alone.

The PEG ratio, a measure that relates price-to-earnings ratio to earnings growth, is currently at 0.6. While a PEG below 1 can sometimes indicate undervaluation, in this context it reflects the market’s cautious stance given the company’s inconsistent fundamentals and financial health. The stock is trading at valuations that are considered risky compared to its historical averages, signalling potential downside for investors.

Financial Trend Analysis

Financially, Sundaram Multi Pap Ltd shows a very positive grade, which may seem contradictory given the other concerns. This is largely due to the recent surge in profits and some improvement in financial metrics. However, this positive trend has not translated into stock price appreciation, as the company has consistently underperformed the benchmark indices.

Over the last three years, the stock has underperformed the BSE500 index in each annual period, with a one-year return of -36.27% as of 04 March 2026. The downward trend is also evident in shorter time frames, with the stock declining 6.47% in the last day, 15.58% over the past week, and 35.32% over six months. These figures highlight persistent challenges in market sentiment and investor confidence.

Technical Outlook

The technical grade for Sundaram Multi Pap Ltd is bearish, reflecting negative momentum and weak price action. The stock’s recent performance shows consistent declines across multiple time horizons, indicating selling pressure and a lack of buying interest. This bearish technical stance reinforces the caution advised by the Strong Sell rating, as it suggests limited near-term recovery potential based on chart patterns and market behaviour.

Summary for Investors

In summary, Sundaram Multi Pap Ltd’s current Strong Sell rating by MarketsMOJO is supported by a combination of below-average quality metrics, risky valuation levels, a mixed but ultimately negative financial trend, and bearish technical indicators. Investors should be aware that despite some positive profit growth, the company faces significant operational and financial challenges that have led to sustained underperformance relative to market benchmarks.

For those considering exposure to this stock, the rating implies a high level of caution. The company’s weak capital efficiency, poor debt servicing ability, and negative price momentum suggest that the risks currently outweigh the potential rewards. Monitoring ongoing financial results and market developments will be essential for reassessing the stock’s outlook in the future.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Performance Metrics in Detail

Examining the stock’s returns as of 04 March 2026 reveals a consistent downward trajectory. The stock has lost 6.47% in a single day and 15.58% over the past week, signalling short-term volatility and selling pressure. Over the last month, the decline deepens to 23.08%, and the three-month return stands at -27.37%. Half-year and year-to-date returns are similarly negative at -35.32% and -27.78%, respectively. The one-year return of -36.27% starkly contrasts with the company’s profit growth, underscoring the disconnect between earnings and market valuation.

Debt and Profitability Concerns

The company’s weak EBIT to Interest ratio of 0.40 highlights a critical vulnerability in its financial structure. This low coverage ratio means that earnings are insufficient to comfortably meet interest obligations, raising concerns about liquidity and solvency. Investors typically view such metrics as red flags, especially in uncertain economic environments.

Operating profits have been negative, contributing to the risky valuation grade. Although profits have surged recently, the negative operating profit history and poor long-term growth temper optimism. The company’s operating profit growth rate of 13.96% annually over five years is modest and insufficient to offset other weaknesses.

Market Position and Sector Context

Sundaram Multi Pap Ltd operates within the miscellaneous sector and is classified as a microcap company. Microcap stocks often carry higher volatility and risk due to lower liquidity and less market coverage. This context further justifies the cautious Strong Sell rating, as smaller companies can be more vulnerable to market fluctuations and operational challenges.

Investor Takeaway

For investors, the Strong Sell rating serves as a clear signal to approach Sundaram Multi Pap Ltd with caution. The combination of weak quality metrics, risky valuation, bearish technicals, and inconsistent financial trends suggests that the stock is not currently a favourable investment. Those holding the stock may consider reassessing their positions, while prospective investors should carefully weigh the risks before committing capital.

Continued monitoring of the company’s financial health, market conditions, and sector developments will be crucial to determine if and when the stock’s outlook improves. Until then, the Strong Sell rating reflects the prevailing consensus that Sundaram Multi Pap Ltd faces significant headwinds that are likely to persist in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Sundaram Multi Pap Ltd falling/rising?
Mar 03 2026 01:09 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Feb 21 2026 10:10 AM IST
share
Share Via
Are Sundaram Multi Pap Ltd latest results good or bad?
Feb 14 2026 07:43 PM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Feb 10 2026 10:10 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 30 2026 10:11 AM IST
share
Share Via